Regenerative Sciences Announces Knee Osteoarthritis Clinical Research Study

Regenerative Sciences Inc. has begun a new clinical research study on the use of autologous stem cells for treating knee osteoarthritis.

The study is being conducted in Chicago, Ill., in collaboration with Mitchell Sheinkop, M.D. Qualified candidates currently are being recruited for the study.

The Regenexx procedure uses a patient’s own stem cells to help repair various common injuries and degenerative conditions, including cartilage lesions, torn ligaments and tendons, osteoarthritis and bulging spinal discs. The procedures offer a viable alternative to surgery.

Knee osteoarthritis curremtly is one of the most common degenerative joint conditions in the United States, affecting millions of individuals and resulting in approximately 700,000 knee replacements each year. The study, which the company claims is the first of its kind, will measure and compare patient outcomes following the Regenexx-SD, or “same day,” stem cell therapy against those from a control group of patients undergoing exercise therapy and other non-surgical modalities, as well as historical results of patients who have undergone knee replacement surgery.

“Regenexx procedures are the most researched stem cell procedures in the United States and have been the subject of many published research papers on the use of stem cells for orthopedic conditions,” said Christopher J. Centeno, M.D., CEO of Regenerative Sciences. “This study is a big step in quantifying the effectiveness of the procedure for knee osteoarthritis, with the added benefit of bringing additional awareness of regenerative stem cell treatments to both the medical community and the general public.”

“Having performed thousands of knee replacements during my 38 years as a joint replacement surgeon, I’m excited to be leading this important study,”said Mitchell Sheinkop, M.D., who is heading the study. “I have seen the ability of these new biologic treatments to help heal injuries and degenerative conditions without surgery and I believe they will soon become the new normal for treating many orthopedic conditions.”

Regenerative Sciences LLC is an extension of the medical practice of the Centeno-Schultz clinic. The company has developed patent-pending procedures that use a person’s own stem cells and blood growth factors to help regenerate bone and cartilage. The firm is headquartered in Broomfield, Colo.